Movement Alert｜WuXi Biologics Rises 3.39% in Regular Trading, Sustained Buybacks and CXO Sector Resonance Drive Momentum

Market Focus09:58

On June 29, WuXi Biologics rose 3.39% in regular trading, reaching HK$34.4 per share, with turnover of HK$254 million.

On the news front, the company has maintained a high-frequency buyback pace, executing on-market repurchases nearly every trading day since early June, with single-day amounts ranging from approximately HK$50 million to HK$100 million. The buyback authorization approved at the June 10 shareholders meeting allows repurchases of up to approximately 412 million shares. Additionally, the company's 25th drug substance manufacturing facility recently completed its first GMP production batch with zero deviations, signaling continued capacity expansion.

Within the Life Sciences Tools and Services sector, broad-based strength was evident. Among individual stocks, XtalPi rose 6.96%, Pharmaron rose 4.86%, WuXi AppTec rose 3.37%, WuXi XDC rose 3.36%, while Insilico declined 1.05%, reflecting significant sector resonance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1109217352?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 09:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109217352","market":"hk","top_or_hot":-1,"title":"Movement Alert｜WuXi Biologics Rises 3.39% in Regular Trading, Sustained Buybacks and CXO Sector Resonance Drive Momentum","media":"Market Focus","content":"<p><p>On June 29, WuXi Biologics rose 3.39% in regular trading, reaching HK$34.4 per share, with turnover of HK$254 million.</p><p>On the news front, the company has maintained a high-frequency buyback pace, executing on-market repurchases nearly every trading day since early June, with single-day amounts ranging from approximately HK$50 million to HK$100 million. The buyback authorization approved at the June 10 shareholders meeting allows repurchases of up to approximately 412 million shares. Additionally, the company's 25th drug substance manufacturing facility recently completed its first GMP production batch with zero deviations, signaling continued capacity expansion.</p><p>Within the Life Sciences Tools and Services sector, broad-based strength was evident. Among individual stocks, XtalPi rose 6.96%, Pharmaron rose 4.86%, WuXi AppTec rose 3.37%, WuXi XDC rose 3.36%, while Insilico declined 1.05%, reflecting significant sector resonance.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi Biologics Rises 3.39% in Regular Trading, Sustained Buybacks and CXO Sector Resonance Drive Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi Biologics Rises 3.39% in Regular Trading, Sustained Buybacks and CXO Sector Resonance Drive Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-29 09:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 29, WuXi Biologics rose 3.39% in regular trading, reaching HK$34.4 per share, with turnover of HK$254 million.</p><p>On the news front, the company has maintained a high-frequency buyback pace, executing on-market repurchases nearly every trading day since early June, with single-day amounts ranging from approximately HK$50 million to HK$100 million. The buyback authorization approved at the June 10 shareholders meeting allows repurchases of up to approximately 412 million shares. Additionally, the company's 25th drug substance manufacturing facility recently completed its first GMP production batch with zero deviations, signaling continued capacity expansion.</p><p>Within the Life Sciences Tools and Services sector, broad-based strength was evident. Among individual stocks, XtalPi rose 6.96%, Pharmaron rose 4.86%, WuXi AppTec rose 3.37%, WuXi XDC rose 3.36%, while Insilico declined 1.05%, reflecting significant sector resonance.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1109217352","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109217352","pubTimestamp":1782698292,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 29, WuXi Biologics rose 3.39% in regular trading, reaching HK$34.4 per share, with turnover of HK$254 million.On the news front, the company has maintained a high-frequency buyback pace,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"动向提示|药明生物常规交易涨3.39%持续回购与CXO板块共振驱动动能","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"On June 29, WuXi Biologics rose 3.39% in regular trading, reaching HK$34.4 per share, with turnover of HK$254 million.On the news front, the company has maintained a high-frequency buyback pace, executing on-market repurchases nearly every trading day since early June, with single-day amounts ranging from approximately HK$50 million to HK$100 million. The buyback authorization approved at the June 10 shareholders meeting allows repurchases of up to approximately 412 million shares. Additionally, the company's 25th drug substance manufacturing facility recently completed its first GMP production batch with zero deviations, signaling continued capacity expansion.Within the Life Sciences Tools and Services sector, broad-based strength was evident. Among individual stocks, XtalPi rose 6.96%, Pharmaron rose 4.86%, WuXi AppTec rose 3.37%, WuXi XDC rose 3.36%, while Insilico declined 1.05%, reflecting significant sector resonance.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1109217352","isCrawlerRequest":true}